ASTRAZENECA PHARMA INDIA
Back to Balance Sheet
|
ASTRAZENECA PHARMA INDIA Last 5 Year Deferred Tax Assets / Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹-42 Cr | ₹-21 Cr | ₹-21 Cr | ₹-16 Cr | ₹-15 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of ASTRAZENECA PHARMA INDIA ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹-42 Cr |
| Mar2024 | ₹-21 Cr |
| Mar2023 | ₹-21 Cr |
| Mar2022 | ₹-16 Cr |
| Mar2021 | ₹-15 Cr |
How is Deferred Tax Assets / Liabilities of ASTRAZENECA PHARMA INDIA Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-42 Cr | Negative | |
| Mar2024 | ₹-21 Cr | Negative | |
| Mar2023 | ₹-21 Cr | Negative | |
| Mar2022 | ₹-16 Cr | Negative | |
| Mar2021 | ₹-15 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of ASTRAZENECA PHARMA INDIA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ASTRAZENECA PHARMA INDIA | ₹23,028.8 Cr | 1.7% | 0.4% | 39.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹433,068.0 Cr | -0.2% | 7.1% | 1.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹171,847.0 Cr | 0.8% | -6% | 4.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹127,985.0 Cr | 1.2% | 6.4% | 13.1% | Stock Analytics | |
| CIPLA | ₹122,826.0 Cr | -0.2% | 1.4% | -0.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,418.0 Cr | 1.2% | 5.8% | 4.2% | Stock Analytics | |
ASTRAZENECA PHARMA INDIA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ASTRAZENECA PHARMA INDIA | 1.7% |
0.4% |
39.3% |
| SENSEX | 0% |
2.7% |
6.8% |
You may also like the below Video Courses